WJ doesn’t treat joint pain, but rather addresses the underlying structural tissue defect(s) that is often the primary culprit of joint pain.
WJ tissue is immune-privileged and tested extensively for communicable diseases, leading to a lower risk of adverse events. In 5 years of operation, Regenative Labs’ products have never incurred an adverse event.
When applied to defects in articular cartilage or other soft tissues, the collagen-based ECM provides tensile strength and protects surrounding tissues from mechanical stress. In addition, the ECM remains in the affected area long after application, providing a structural scaffold for the body’s natural healing process to unfold.
The problem with conventional treatment methods for joint pain
They treat the symptom (pain), instead of the root cause
Higher risk for adverse events
Provide only short-term solutions at best
When Wharton’s jelly is applied to defects in the articular cartilage scaffold, several case studies have reported the alleviation of symptoms associated with structural defects.